Comparative Efficacy of Ruksha Purva and Sneha Purva Siravedhana Combined with Nitya Virechana in the Management of Yakrutodara (Non-Alcoholic Fatty Liver Disease): A Randomized Clinical Trial
Year: 2026
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Abstract: Background:Non-alcoholic fatty liver disease (NAFLD) is a common chronic liver disorder associated with obesity, insulin resistance, and metabolic syndrome. In Ayurveda, its clinical manifestations may be correlated with Yakrutodara, characterized by Mandagni, Kapha-Pitta Dushti, Meda Dhatu Vriddhi, and Srotorodha. Ayurvedic interventions such as Siravedhana, Udvartana, and Nitya Virechana are traditionally employed to address these pathological changes. Objective:To evaluate and compare the efficacy of Ruksha Purva Siravedhana and Sneha Purva Siravedhana, each combined with Udvartana and Nitya Virechana, in the management of Yakrutodara (NAFLD). Materials and Methods: An open-label, randomized comparative clinical trial was conducted in 30 patients diagnosed with Yakrutodara (NAFLD). Participants were randomly allocated into two groups of 15 each using a computergenerated randomization sequence. Group A received Ruksha Purva Siravedhana along with Udvartana and Nitya Virechana, whereas Group B received Sneha Purva Siravedhana, preceded by Sadhyo Snehapana with Murchhita Go Ghrita, along with the same treatment regimen. Subjective parameters, including Ajirna, Aruchi, Adhmana, Chhardi, Atilalasrava, and Vibandha, and objective parameters, including serum SGPT, SGOT, and Fatty Liver Index (FLI), were assessed before and after treatment. Statistical analysis was performed using IBM SPSS Statistics. Results: All 30 participants completed the study without treatment-related adverse events. Both groups showed significant improvement in major subjective symptoms and a significant reduction in FLI. Group B demonstrated significantly greater improvement in Vibandha compared with Group A. Group A showed no significant changes in SGPT or SGOT, whereas Group B demonstrated a statistically significant increase in both liver enzyme levels after treatment. Conclusion: Both treatment protocols improved clinical manifestations and reduced hepatic steatosis. Sneha Purva Siravedhana was more effective for Vibandha, while Ruksha Purva Siravedhana maintained stable liver enzyme levels. Further studies with larger samples are warranted.
Authors: Riva A. Joshi, Sangeeta H. Toshikhane
Institution: Parul University
Language: English
Subfield: Complementary and alternative medicine
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7235385055
